Absolute lymphocyte count – Communicable Diseases Research

Distinct Immune Phenotypes and Cytokine Profiles in Children with Differing Severity of COVID-19

Article

Published on 2022-11-012022-11-15
Journal: The Pediatric Infectious Disease Journal [Category] SARS, 진단, 치료기술,

Efficacy of polyherbal formulations for prevention of COVID-19 infection in high-risk subjects: A randomized open-label controlled clinical trial

Randomized Controlled Trial

Published on 2022-09-012022-10-04
Journal: Phytotherapy research : PTR [Category] COVID19(2023년), SARS, 임상,

Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia

Research

Published on 2022-08-262022-10-05
Journal: Scientific Reports [Category] 바이오마커,

Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection

Article

Published on 2022-08-152022-11-15
Journal: Frontiers in Immunology [Category] SARS, 바이오마커,

[키워드] Absolute lymphocyte count acute respiratory syndrome Bio-Plex 200 system C-reactive protein (CRP CCL2 chemokine Clinical practice Cluster coronavirus Coronavirus disease 2019 correlated correlation COVID-19 Critical cytokine cytokine level cytokine release Cytokine release syndrome death deaths diagnosed with COVID-19 different time point evaluated examined Factor GM-CSF IL-10 IL-8 immune immune checkpoint Immunoglobulin Impact Increased Infection inflammatory markers involved Laboratory Ligand marker motif multiplexed immunoassay nine pandemic Patient patients with SARS-CoV-2 performed Platelet poor prognosis positive correlation procalcitonin Prognosis prognostic Protein Quantitative SARS-CoV-2 SARS-CoV-2-infected patients serum sample shown significantly higher Stratification survivor Survivors T-cell virus entry were measured
[DOI] 10.3389/fimmu.2022.903419 PMC 바로가기

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection

COVID-19 감염으로 면역저하된 소아 및 청소년에서 감염 및 혈청전환의 중증도를 예측하는 요인

Observational Study

Published on 2022-08-032022-09-12
Journal: Frontiers in Immunology [Category] SARS, 임상, 진단,

[키워드] Absolute lymphocyte count absolute neutrophil count Analysis ANC anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibody Antibody Response blood sample body mass index Cancer Cell Chemotherapy children Clinical severity comorbid condition COVID COVID 19 COVID-19 infection Critical Cutoff defined determine died Factor FIVE Hematologic malignancy Hematological malignancy high-risk population Hospitalized ICU Immunocompromised Immunocompromised patient immunosuppressive Infection Laboratory less Level lowest median moderate multivariable model observation outcome outcomes Patient patients PCR Pediatric patient predict Predictive receiving required Respiratory Support SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection Seroconversion seroconversion rate severity Severity of infection stem cell transplant steroid the patient therapy treated univariable vaccination variable was used with COVID-19
[DOI] 10.3389/fimmu.2022.919762 PMC 바로가기 [Article Type] Observational Study

Combination of cycle threshold time, absolute lymphocyte count and neutrophil:lymphocyte ratio is predictive of hypoxia in patients with SARS-CoV-2 infection

Article

Published on 2022-07-062023-07-07
Journal: Transactions of the Royal Society of Tropical Medi [Category] COVID19(2023년),

[키워드] Absolute lymphocyte count cycle threshold time neutrophil:lymphocyte ratio respiratory compromise. SARS-CoV-2
[DOI] 10.1093/trstmh/trab182 PMC 바로가기

COVID-19 death and kidney disease in a multiracial Asian country

Observational Study

Published on 2022-07-012022-10-05
Journal: Nephrology (Carlton, Vic.) [Category] 임상,

Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study

COVID-19의 불길을 부채질하여 rhino-orbito-cerebral mucormycosis를 일으키는 병원성 요인: 관찰 연구

Observational Study

Published on 2022-05-012022-09-11
Journal: Journal de mycologie médicale [Category] COVID19(2023년), SARS, 변종, 임상,

[키워드] Absolute lymphocyte count absolute neutrophil count age ALC ANC Clinical severity Comorbidities coronavirus disease Coronavirus disease-19 COVID COVID-19 COVID-19 pandemic COVID-19 severity Cytokine storm D-dimer Delta delta variant Delta variants diabete diabetes Diabetic diabetic ketoacidosis element elevated Factor fanning feature ferritin First wave first-wave Gender Hyperferritinemia identify IL-6 incidence interleukin interleukin-6 lymphocyte male males Mucormycosis neutrophil no significant difference pathogenic Pathways Patient Platelet Platelet count renal dysfunction retrospective Rhino-orbito-cerebral mucormycosis second wave Serum ferritin severe COVID-19 significant difference significantly steroid steroid therapy Steroids therapy treated was done while
[DOI] 10.1016/j.mycmed.2022.101252 PMC 바로가기 [Article Type] Observational Study

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

세 번째 COVID-19 백신 접종에 대한 면역 반응은 핀골리모드로 치료받은 다발성 경화증 환자의 림프구 수와 관련이 있습니다

Randomized Controlled Trial

Published on 2022-05-012022-09-11
Journal: Journal of Neurology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술,

[키워드] Absolute lymphocyte count adaptive adaptive cellular immunity BNT162b2 BNT162b2 vaccine both groups Cell Cellular immune response cellular immunity clinical trial correlated COVID-19 COVID-19 vaccination COVID-19 vaccine develop dose Efficacy fingolimod groups humoral Humoral immunity IgG IgG antibody IgG immune response immune response immune responses in both groups lymphocyte Lymphocyte count majority memory memory B memory B cell Multiple multiple sclerosis non-responder Patient patients patients treated Pfizer positive Protective Randomized randomized clinical trial relapsing SARS-CoV-2 vaccination SARS-CoV-2 vaccine single-center Specific T cell therapy Third BNT162b2 SARS-CoV-2 vaccine dose. Treatment two groups Vaccine were assessed
[DOI] 10.1007/s00415-022-11030-0 PMC 바로가기 [Article Type] Randomized Controlled Trial

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study

만성 림프구성 백혈병에서 SARS-CoV-2 백신의 체액 및 세포 면역원성: 전향적 코호트 연구

Clinical Trial

Published on 2022-03-222022-09-11
Journal: Blood advances [Category] MERS, SARS, 변종, 임상, 진단,

[키워드] Absolute lymphocyte count accompanied acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody Antibody Response Antibody responses assays bead-based multiplex immunoassay binding cellular characterization chronic chronic lymphocytic leukemia clinical benefit CLL CLL patient Cohort coronavirus COVID-19 mortality demonstrated develop dose elicited framework function functional IgG immunoassay induce interferon interferon-γ leukemia lymphocyte Lymphocytic leukemia molecular mechanism molecular mechanisms mRNA-based vaccine outcome Patient Previous studies previous study prospective cohort study provide RBD Receptor binding domain Registered respiratory response rate responses SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serologic response serologic responses severe acute respiratory syndrome Coronavirus Spike-specific T-cell responses T-cell T-cell Response T-cell responses tested Therapies therapy treatment-naïve patient treatment-naïve patients Trial vaccination Vaccine variant was performed wild-type
[DOI] 10.1182/bloodadvances.2021006627 PMC 바로가기 [Article Type] Clinical Trial